Schedule 14A
Please expand your discussion to address how the experience of the Interim Lead Independent Director is brought to bear in connection with your board’s role in risk oversight.
This letter is in response to the letter, dated September 2, 2022 (the “Letter”), of the staff (the “Staff”) of the Division of Corporation Finance of the U.S. Securities and Exchange Commission. The Company respectfully acknowledges the Staff’s comments within the Letter and will enhance its future proxy disclosures to address the Staff’s comments and any material developments to the Company’s risk oversight structure to the extent appropriate and in compliance with Item 407(h) of Regulation S-K. To the extent that you have any questions regarding the response contained in this letter, please do not hesitate to contact me at (614) 947-9403 or [email protected].One letter for all the questions, without numbered answers. Read the reply
Please expand upon the role that your Interim Lead Independent Director plays in the leadership of the board. For example, please enhance your disclosure to address whether or not your Interim Lead Independent Director may: • represent the board in communications with shareholders and other stakeholders; • require board consideration of, and/or override your CEO on, any risk matters; or • provide input on design ofRest of the question
the board itself.
See the reply above.
Please expand upon how your board administers its risk oversight function. For example, please disclose: • why your board elected to retain direct oversight responsibility for certain risks rather than assign oversight to a board committee; • the timeframe over which you evaluate risks (e.g., short-term, intermediate-term, or long-term) and how you apply different oversight standards based upon the immediacy of theRest of the question
risk assessed; • whether you consult with outside advisors and experts to anticipate future threats and trends, and how often you re-assess your risk environment; • how the board interacts with management to address existing risks and identify significant emerging risks; • whether you have a Chief Compliance Officer and to whom this position reports; and • how your risk oversight process aligns with your disclosure controls and procedures.
See the reply above.
Also in this review: closing letter, 2022-10-20